AstraZeneca appoints Nazneen Rahman to Board of Directors
Professor Nazneen Rahman today joined the Board of Directors and Science Committee at AstraZeneca.
Rahman is head of the Divison of Genetics and Epidemiology at the Institute of Cancer Research in London. She is also the head of the cancer genetics unit at the Royal Marsden NHS Foundation.
Her research combines clinical and scientific knowledge to create new treatments for human disease genes, in particular, cancer predisposition genes.
“We are delighted to welcome Professor Rahman to our Board and Science Committee. She brings world-renowned expertise in genetic research with a focus on cancer, which is a strategic therapy area for our business,” said Leif Johansson, chairman of AstraZeneca.